The growth of biological drug products is having a significant effect on the way drugs and devices are developed and commercialized. The clinical application of these drugs is often limited by a lack of desirable attributes for adequate absorption or distribution. Cooperation between device designers and drug developers is occurring much earlier in the drug development cycle, allowing device designs in many cases to be tailored to the bioavailability targets and pharmacokinetic profiles of specific drug therapies. The powerful physiological effects of antibodies, hormones and other biological drugs also increase the need for safety and adherence, escalating the importance of downstream product decisions.
Self-administered Biologicals Report Prospectus (Download PDF)
Self-administered Biologicals Report Order Form (Download PDF)
What You Will Learn
• What biological drugs are currently marketed for self-administration, how are they positioned in the market, who markets them and what are the product specifics?
• Who are the important biological drug suppliers, their collaborations and their capabilities?
• What are the major factors driving biological drug demand?
• How important are drug developer-ecosystem partner relationships and what are the key alliances in the industry?
• What are the essential design factors, material selection issues, technologies and market development issues for biological drug products?
• How are biological drugs aligned with various drug classes and therapeutic markets?
• What are the significant economic, technology, and regulatory factors affecting biological drugs?
Summary of Contents
Biological Drug Market Dynamics
Evolution in Drug Demand
The Growth of Self Administration
Self-administered Biologicals – Product Factors
Specific Patient Populations
Self Administered Biologicals – Delivery Strategies
SA Biologicals – Product & Strategy Assessments
GLP-1 Receptor Agonists
A Look Ahead – Development-stage SA Biologicals
Therapeutic Sector Analysis & Forecasts
Device Branding & DTC Marketing
Patient Compliance and Ease of Use